Big Pharma keeps using R&D costs to justify high launch prices even after peer-reviewed research…
Americans For Pharma Reform
Visit on X@BustBigPharma5.6K followers
102,084 views
Big Pharma keeps using R&D costs to justify high launch prices even after peer-reviewed research found no association between the two.
The argument persists because it protects profits and blocks reform. Rob Burgess follows the receipts.
Comments
Comments from the original post on X (Twitter)
No comments yet
